retatrutide phase 2 study results Let's talk about a new weight loss medication: retrarutide. is a triple hormone receptor agonist that suppresses appetite; it also boosts metabolism and increases fat burning, making it one of the A Clinician's Guide to Retatrutide

The GLP-1 Journey guides you through diet, lifestyle, and supplement strategies designed to help you feel your best while using the medication

Any suspected side effects in trial participants should be reported to the trial investigator and, where appropriate, via the MHRA Yellow Card scheme at yellowcard.mhra.gov.uk

Human dosing strategies are still being refined

Who takes Toujeo Toujeo serves a specific patient population

Recent studies have shown that patients on high-dose semaglutide can lose an average of 15% to 20% of their body weight, a level previously achievable only with bariatric surgery

doi: 10.3892/IJMM.2025.5515 Summary Keywords glucagon-like peptide-1, type 2 diabetes, endothelial function, obesity, metabolic syndrome Citation Hammad BF, Zafar N, Ullah M, Faisal SJ, Iftikhar F, Waheed H, Muzaffar MW, Ahmed K, Ashraf F, Zahid K, Akhtar M and Mahmmoud Fadelallah Eljack M (2025) Exploring the multifaceted roles of GLP-1 receptor agonists